A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
NCT04295018
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
C-CAR088
Sponsor
Peking Union Medical College Hospital
Collaborators
[object Object]